KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

HCA Healthcare (HCA) Shares Repurchased (2016 - 2026)

HCA Healthcare (HCA) has disclosed Shares Repurchased for 13 consecutive years, with $1.6 billion as the latest value for Q1 2026.

  • For Q1 2026, Shares Repurchased fell 37.31% year-over-year to $1.6 billion; the TTM value through Mar 2026 reached $9.1 billion, up 23.94%, while the annual FY2025 figure was $10.1 billion, 66.62% up from the prior year.
  • Shares Repurchased hit $1.6 billion in Q1 2026 for HCA Healthcare, down from $2.6 billion in the prior quarter.
  • Across five years, Shares Repurchased topped out at $2.7 billion in Q2 2022 and bottomed at $698.0 million in Q3 2022.
  • Average Shares Repurchased over 5 years is $1.7 billion, with a median of $1.6 billion recorded in 2026.
  • Year-over-year, Shares Repurchased tumbled 70.03% in 2022 and then soared 112.37% in 2025.
  • HCA Healthcare's Shares Repurchased stood at $1.5 billion in 2022, then plummeted by 40.09% to $910.0 million in 2023, then skyrocketed by 86.81% to $1.7 billion in 2024, then soared by 50.47% to $2.6 billion in 2025, then plummeted by 38.58% to $1.6 billion in 2026.
  • According to Business Quant data, Shares Repurchased over the past three periods came in at $1.6 billion, $2.6 billion, and $2.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.